A source tells Bloomberg that Stephane Bancel will step down as the company’s Chief Commercial Officer, but retain the role of Moderna’s (MRNA) Chief Executive Officer.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Carisma to present new data on CAR-M therapy for hepatocellular carcinoma
- Trump vs. Harris: The Stocks Poised to Move After Election Day
- VOO ETF Update, 11/5/2024
- Moderna price target lowered to $59 from $70 at JPMorgan
- Options Volatility and Implied Earnings Moves This Week, November 04 – November 08, 2024